Issue 4/2018
Content (17 Articles)
Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy
S. Rodríguez, M. Arenas, C. Gutierrez, J. Richart, J. Perez-Calatayud, F. Celada, M. Santos, A. Rovirosa
Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH
P. Garrido, A. Aldaz, R. Vera, M. A. Calleja, E. de Álava, M. Martín, X. Matías-Guiu, J. Palacios
The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation
C. Wang, H. Xie, D. Lu, Q. Ling, P. Jin, H. Li, R. Zhuang, X. Xu, S. Zheng
miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer
M. Kang, Y. Li, Y. Zhao, S. He, J. Shi
Analysis of blood markers for early breast cancer diagnosis
J. Bayo, M. A. Castaño, F. Rivera, F. Navarro
Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy
C. Marín Hernández, A. Piñero Madrona, P. J. Gil Vázquez, P. J. Galindo Fernández, G. Ruiz Merino, J. L. Alonso Romero, P. Parrilla Paricio
The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients
O. C. Guler, B. Engels, C. Onal, H. Everaert, R. Van den Begin, T. Gevaert, M. de Ridder
High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells
Z. Zhao, Y. Xu, J. Lu, J. Xue, P. Liu
Treatment of childhood astrocytomas with irinotecan and cisplatin
J. Mora, S. Perez-Jaume, O. Cruz
Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine
J. Stritzelberger, L. Distel, R. Buslei, R. Fietkau, F. Putz
Current situation in gynecological oncology training in Spain: where we are and where we want to go
P. Padilla-Iserte, L. Minig, I. Zapardiel, L. Chiva, R. Laky, J. de Santiago
Prediction of neoadjuvant chemotherapy response using diffuse optical spectroscopy in breast cancer
Ying-hua Yu, Xiao Zhu, Qin-guo Mo, Ying Cui
NFBD1/MDC1 participates in the regulation of proliferation and apoptosis in human laryngeal squamous cell carcinoma
X. Liu, Z. Qiu, Z. Wang, W. Zuo, Z. Gong, C. Liu, Q. Zeng, Y. Qian, L. Jiang, Y. Li, Y. Bu, G. Hu
Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls
R. de Cássia Viu Carrara, A. M. Fontes, K. J. Abraham, M. D. Orellana, S. K. Haddad, P. V. B. Palma, R. A. Panepucci, M. A. Zago, D. T. Covas
Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer
O. Abdel-Rahman
Correction to: High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells
Z. Zhao, Y. Xu, J. Lu, J. Xue, P. Liu
Correction to: SEOM clinical guidelines for endometrial cancer (2017)
A. Santaballa, X. Matías-Guiu, A. Redondo, N. Carballo, M. Gil, C. Gómez, M. Gorostidi, M. Gutierrez, A. Gónzalez-Martín